FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

23856311000001100: Giotrif 20mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 05-Feb 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
77456601000001119 Giotrif 20mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
77456701000001112 Giotrif 20mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Giotrif 20mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Giotrif 20mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Giotrif 20mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Giotrif 20mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets Is a Afatinib 20mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Giotrif 20mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets Has AMP Giotrif 20mg tablets (Boehringer Ingelheim Ltd) true Inferred relationship Existential restriction modifier
Giotrif 20mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Giotrif 20mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Giotrif 20mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Giotrif 20mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Giotrif 20mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient Afatinib false Inferred relationship Existential restriction modifier
Giotrif 20mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Giotrif 20mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Giotrif 20mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Giotrif 20mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Giotrif 20mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient Afatinib false Inferred relationship Existential restriction modifier
Giotrif 20mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient Afatinib dimaleate true Inferred relationship Existential restriction modifier
Giotrif 20mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Afatinib true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start